Tempest Therapeutics (TPST) Institutional Ownership $0.92 -0.03 (-3.17%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$0.92 +0.01 (+0.77%) As of 01/31/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$406.18KNumber ofInstitutional Sellers(last 12 months)0 Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Tempest Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% 11/15/2024XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024Empower Advisory Group LLC35,000$49K0.0%N/A0.139% 10/29/2024Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024Virtu Financial LLC28,574$112K0.0%+69.2%0.129% 2/15/2024MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022Maven Securities LTD77,377$409K0.0%-39.0%1.120% Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021Franklin Resources Inc.15,240$221K0.0%N/A0.227% 11/12/2021Renaissance Technologies LLC34,104$493K0.0%+26.9%0.509% 11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234% 11/9/2021Monashee Investment Management LLC60,000$868K0.2%-47.2%0.896% 8/18/2021Ikarian Capital LLC89,865$1.01M0.1%N/A7.076% 8/17/2021Boothbay Fund Management LLC10,477$117K0.0%N/A0.825% 8/16/2021Maven Securities LTD106,628$1.20M0.0%N/A8.396% 8/13/2021Renaissance Technologies LLC26,867$300K0.0%N/A2.116% 8/13/2021Knott David M13,833$155K0.1%N/A1.089% 8/13/2021Vanguard Group Inc.61,150$683K0.0%N/A4.815% 8/13/2021FMR LLC647,898$7.24M0.0%N/A51.016% 8/12/2021Monashee Investment Management LLC113,644$1.27M0.2%N/A8.948% 5/19/2021Squarepoint Ops LLC84,879$102K0.0%N/A0.446% 5/17/2021Ikarian Capital LLC1,348,021$1.62M0.1%+897.1%7.079% 5/17/2021Goldman Sachs Group Inc.20,883$25K0.0%-50.9%0.110% 5/14/2021Dimensional Fund Advisors LP51,219$61K0.0%+259.3%0.269% 5/14/2021Monashee Investment Management LLC500,000$600K0.1%N/A2.626% 5/13/2021Barclays PLC42,638$51K0.0%-90.8%0.224% 5/13/2021Renaissance Technologies LLC924,801$1.11M0.0%+66.0%4.856% 5/13/2021Knott David M137,900$165K0.1%N/A0.724% 5/11/2021Acadian Asset Management LLC291,230$350K0.0%+189.9%1.529% 5/7/2021BlackRock Inc.139,319$167K0.0%+9.8%0.732% 2/24/2021Virtu Financial LLC30,755$66K0.0%N/A0.162% 2/19/2021JPMorgan Chase & Co.75,264$161K0.0%+8,328.2%0.396% 2/11/2021Barclays PLC464,390$994K0.0%+355.7%2.444% 2/10/2021Renaissance Technologies LLC557,108$1.19M0.0%+4.1%2.932% 2/9/2021Bank of New York Mellon Corp56,397$121K0.0%N/A0.297% (Data available from 1/1/2016 forward) TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 9 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Rock Springs Capital Management LP ($681K), Geode Capital Management LLC ($308K), Sectoral Asset Management Inc. ($279K), Virtu Financial LLC ($112K), Fullcircle Wealth LLC ($87K), Dimensional Fund Advisors LP ($55K), and Empower Advisory Group LLC ($49K).Learn more on TPST's institutional investors. What percentage of Tempest Therapeutics stock is owned by institutional investors? 22.52% of Tempest Therapeutics stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics stock? The following institutional investors have purchased Tempest Therapeutics stock in the last 24 months: Sectoral Asset Management Inc. ($219.39K), Geode Capital Management LLC ($65.83K), Fullcircle Wealth LLC ($62K), Empower Advisory Group LLC ($35K), Dimensional Fund Advisors LP ($25.08K), XTX Topco Ltd ($23.99K), and Virtu Financial LLC ($11.69K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 452,982 shares in the last 24 months. This purchase volume represents approximately $684.81K in transactions. Which Tempest Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Tempest Therapeutics stock in the last 24 months: Rock Springs Capital Management LP ($287.44K). How much institutional selling is happening at Tempest Therapeutics? Institutional investors have sold a total of 287,440 shares in the last 24 months. This volume of shares sold represents approximately $365.05K in transactions. Related Companies FATE Major Shareholders KYTX Major Shareholders BMEA Major Shareholders TIL Major Shareholders IPHA Major Shareholders FTLF Major Shareholders ADAP Major Shareholders ARTV Major Shareholders PBYI Major Shareholders VTYX Major Shareholders This page (NASDAQ:TPST) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
